ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

Ohio State Becomes 18th Comprehensive Center; UCLA Needs Only To Overcome “Minor” Problems

April 16, 1976

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990